Sinovac Pharmaceutical’s overseas product infliximab was approved for marketing in Thailand

According to Sinovac Pharmaceutical news, the infliximab biosimilar drug (Reminton) introduced by Sinovac Pharmaceutical has recently been approved for marketing by the Thai Food and Drug Administration (Thai FDA). So far, this product has successfully gained access to many countries and regions including Peru, Indonesia, Pakistan, Bangladesh, and Malaysia, and the internationalization process is advancing rapidly.